Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, BridgeBio Pharma Inc’s stock clocked out at $35.00, down -1.70% from its previous closing price of $35.60. In other words, the price has decreased by -$1.70 from its previous closing price. On the day, 4.09 million shares were traded. BBIO stock price reached its highest trading level at $36.2376 during the session, while it also had its lowest trading level at $34.56.
Ratios:
To gain a deeper understanding of BBIO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.19 and its Current Ratio is at 3.19.
On September 04, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $46.Piper Sandler initiated its Overweight rating on September 04, 2024, with a $46 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 19 ’24 when Kumar Neil sold 27,389 shares for $22.41 per share. The transaction valued at 613,826 led to the insider holds 4,897,443 shares of the business.
STEPHENSON BRIAN C sold 4,156 shares of BBIO for $93,137 on Nov 19 ’24. The Secretary, Treasurer & CFO now owns 93,758 shares after completing the transaction at $22.41 per share. On Nov 19 ’24, another insider, BRIAN STEPHENSON, who serves as the Officer of the company, bought 4,156 shares for $22.35 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBIO now has a Market Capitalization of 6614649856 and an Enterprise Value of 8089597952. For the stock, the TTM Price-to-Sale (P/S) ratio is 30.38. Its current Enterprise Value per Revenue stands at 37.148 whereas that against EBITDA is -15.865.
Stock Price History:
The Beta on a monthly basis for BBIO is 1.02, which has changed by -0.052050054 over the last 52 weeks, in comparison to a change of 0.22212577 over the same period for the S&P500. Over the past 52 weeks, BBIO has reached a high of $41.04, while it has fallen to a 52-week low of $21.62. The 50-Day Moving Average of the stock is 28.93%, while the 200-Day Moving Average is calculated to be 31.26%.
Shares Statistics:
It appears that BBIO traded 2.17M shares on average per day over the past three months and 2890270 shares per day over the past ten days. A total of 188.99M shares are outstanding, with a floating share count of 147.77M. Insiders hold about 21.81% of the company’s shares, while institutions hold 75.83% stake in the company. Shares short for BBIO as of 1735603200 were 19299148 with a Short Ratio of 8.90, compared to 1732838400 on 16998642. Therefore, it implies a Short% of Shares Outstanding of 19299148 and a Short% of Float of 15.68.
